These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18193068)

  • 1. ZP120 causes relaxation by pre-junctional inhibition of noradrenergic neurotransmission in rat mesenteric resistance arteries.
    Simonsen U; Laursen BE; Petersen JS
    Br J Pharmacol; 2008 Mar; 153(6):1185-94. PubMed ID: 18193068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic characterization of ZP120 (Ac-RYYRWKKKKKKK-NH2), a novel, functionally selective nociceptin/orphanin FQ peptide receptor partial agonist with sodium-potassium-sparing aquaretic activity.
    Kapusta DR; Thorkildsen C; Kenigs VA; Meier E; Vinge MM; Quist C; Petersen JS
    J Pharmacol Exp Ther; 2005 Aug; 314(2):652-60. PubMed ID: 15855355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120.
    Fischetti C; Rizzi A; Gavioli EC; Marzola G; Trapella C; Guerrini R; Petersen JS; Calo G
    Peptides; 2009 Feb; 30(2):248-55. PubMed ID: 18992780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice.
    Rizzi A; Rizzi D; Marzola G; Regoli D; Larsen BD; Petersen JS; Calo' G
    Br J Pharmacol; 2002 Oct; 137(3):369-74. PubMed ID: 12237257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nociceptin/orphanin FQ peptide receptor agonist Ac-RYYRWKKKKKKK-NH2 (ZP120) induces antinatriuresis in rats by stimulation of amiloride-sensitive sodium reabsorption.
    van Deurs US; Hadrup N; Petersen JS; Christensen S; Jonassen TE
    J Pharmacol Exp Ther; 2009 Feb; 328(2):533-9. PubMed ID: 19028991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nociceptin/orphanin FQ inhibits electrically induced contractions of the human bronchus via NOP receptor activation.
    Basso M; Risse PA; Naline E; Calo G; Guerrini R; Regoli D; Advenier C
    Peptides; 2005 Aug; 26(8):1492-6. PubMed ID: 16042989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional selectivity of nociceptin/orphanin FQ peptide receptor partial agonists on cardiovascular and renal function.
    Kapusta DR; Burmeister MA; Calo' G; Guerrini R; Gottlieb HB; Kenigs VA
    J Pharmacol Exp Ther; 2005 Aug; 314(2):643-51. PubMed ID: 15855356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative study of [(pF)Phe4,Arg14,Lys15]nociceptin/orphanin FQ-NH2 (UFP-102) at NOP receptors in rat periaqueductal gray slices.
    Kuo CJ; Liao YY; Guerrini R; Calo' G; Chiou LC
    Eur J Pharmacol; 2008 Jan; 579(1-3):110-5. PubMed ID: 17976580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmented sensory-motor vasodilatation of the rat mesenteric arterial bed after chronic infusion of the P1-purinoceptor antagonist, DPSPX.
    Relevic V; Rubino A; Burnstock G
    Br J Pharmacol; 1996 Aug; 118(7):1675-80. PubMed ID: 8842431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinflammatory and vasodilator effects of nociceptin/orphanin FQ in the rat mesenteric microcirculation are mediated by histamine.
    Brookes ZL; Stedman EN; Guerrini R; Lawton BK; Calo G; Lambert DG
    Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H2977-85. PubMed ID: 17766480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol.
    Bojnik E; Babos F; Fischetti C; Magyar A; Camarda V; Borsodi A; Bajusz S; Calo' G; Benyhe S
    Brain Res Bull; 2010 Mar; 81(4-5):477-83. PubMed ID: 19800951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ORL1 receptor-mediated inhibition by nociceptin of noradrenaline release from perivascular sympathetic nerve endings of the rat tail artery.
    Bucher B
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):682-5. PubMed ID: 9879729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex.
    Marti M; Stocchi S; Paganini F; Mela F; De Risi C; Calo' G; Guerrini R; Barnes TA; Lambert DG; Beani L; Bianchi C; Morari M
    Br J Pharmacol; 2003 Jan; 138(1):91-8. PubMed ID: 12522077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.
    Rizzi A; Spagnolo B; Wainford RD; Fischetti C; Guerrini R; Marzola G; Baldisserotto A; Salvadori S; Regoli D; Kapusta DR; Calo G
    Peptides; 2007 Jun; 28(6):1240-51. PubMed ID: 17532097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of pancreatic secretion in vitro by nociceptin/orphanin FQ and opioid receptors: a comparative study.
    Linari G; Agostini S; Broccardo M; Petrella C; Improta G
    Pharmacol Res; 2006 Nov; 54(5):356-60. PubMed ID: 16979347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ORL-1 (NOP1) receptor ligand nociceptin/orphanin FQ (N/OFQ) inhibits neurogenic dural vasodilatation in the rat.
    Bartsch T; Akerman S; Goadsby PJ
    Neuropharmacology; 2002 Nov; 43(6):991-8. PubMed ID: 12423668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.
    Molinari S; Camarda V; Rizzi A; Marzola G; Salvadori S; Marzola E; Molinari P; McDonald J; Ko MC; Lambert DG; Calo' G; Guerrini R
    Br J Pharmacol; 2013 Jan; 168(1):151-62. PubMed ID: 22827708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the nociceptin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux.
    D'Agostino B; Marrocco G; De Nardo M; Calò G; Guerrini R; Gallelli L; Advenier C; Rossi F
    Br J Pharmacol; 2005 Mar; 144(6):813-20. PubMed ID: 15685213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions.
    Broccardo M; Linari G; Guerrini R; Agostini S; Petrella C; Improta G
    Peptides; 2005 Sep; 26(9):1590-7. PubMed ID: 16112397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD; Harbuz MS; Jessop DS; Fulford AJ
    Neuroscience; 2006 Sep; 141(4):2051-7. PubMed ID: 16784820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.